IMC Chicago’s Moderna MRNA Stock Holding History

IMC Chicago’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-257,166	Closed	-$12M	–	5868
2025 Q4	$7.58M	Sell	257,166 -167,521	-39%	-$4.55M	﹤0.01%	1428
2025 Q3	$11M	Sell	424,687 -13,996	-3%	-$390K	﹤0.01%	1104
2025 Q2	$12.1M	Sell	438,683 -53,574	-11%	-$1.41M	0.01%	941
2025 Q1	$14M	Buy	+492,257	New	+$17.5M	0.01%	732
2024 Q4	–	Sell	-26,611	Closed	-$1.27M	–	3277
2024 Q3	$1.78M	Sell	26,611 -50,200	-65%	-$4.61M	﹤0.01%	1745
2024 Q2	$9.12M	Buy	+76,811	New	+$9.72M	0.01%	817
2023 Q2	–	Sell	-16,384	Closed	-$2.19M	–	1359
2023 Q1	$2.52M	Buy	+16,384	New	+$2.7M	﹤0.01%	789
2022 Q1	–	Sell	-60,618	Closed	-$10.2M	–	1180
2021 Q4	$15.4M	Buy	+60,618	New	+$17.7M	0.01%	411
2021 Q1	–	Sell	-91,262	Closed	-$13.2M	–	1135
2020 Q4	$9.53M	Buy	91,262 +67,275	+280%	+$6.81M	0.01%	417
2020 Q3	$1.7M	Buy	23,987 +13,717	+134%	+$956K	﹤0.01%	616
2020 Q2	$659K	Buy	+10,270	New	+$562K	﹤0.01%	770

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

IMC Chicago's MRNA Position: Q1 2026 in Review

IMC Chicago sold out of Moderna (MRNA) in Q1 2026, closing a stake of 257,166 shares — an estimated $12M sold.

IMC Chicago first reported a position in MRNA in Q2 2020 and held it in 11 quarters. The position peaked at $15.4M in Q4 2021. 725 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

IMC Chicago reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
IMC Chicago sold 257,166 Moderna shares in Q1 2026, an estimated $12M.
IMC Chicago first reported a position in Moderna in Q2 2020 and held it in 11 quarters.
IMC Chicago's Moderna position peaked at $15.4M in Q4 2021.
725 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.